Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 299.22 Thousand | 292.35 Thousand | 8831.00 | - |
| Cost of Revenue | 21.6 Million | 3.29 Million | 2.98 Million | - |
| Gross Profit | -21.3 Million | -3 Million | -2.97 Million | - |
| Operating Expenses | 299.22 Thousand | 37.28 Million | 20.95 Million | 484.75 Thousand |
| Selling, General and Administrative Expenses | 15.67 Million | 15.26 Million | 12.43 Million | 484.75 Thousand |
| Research and Development Expenses | 23.08 Million | 22.02 Million | 4.12 Million | - |
| Other Expenses | - | 2.97 Million | -1.02 Million | - |
| Cost and Expenses | 49.16 Million | 40.58 Million | 20.95 Million | 484.75 Thousand |
| Operating Income | -47.2 Million | -40.29 Million | -23.92 Million | -484.75 Thousand |
| Interest Expense | 642.88 Thousand | 86.09 Thousand | 9.34 Million | - |
| Income Tax Expense | 96.36 Thousand | -5.87 Million | 44.39 Thousand | -1.16 Million |
| Earnings before Tax | -47.85 Million | -40.49 Million | -30.29 Million | -485.19 Thousand |
| Net Income | -47.94 Million | -34.61 Million | -30.33 Million | -485.19 Thousand |
| Earnings Per Share Basic | -0.12 | -0.11 | -0.11 | -0.00 |
| Earnings Per Share Diluted | -0.12 | -0.11 | -0.11 | -0.00 |
| Weighted Average Shares Outstanding | 386.46 Million | 323.81 Million | 279.76 Million | 277.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 386.46 Million | 323.81 Million | 279.76 Million | 277.46 Million |
| Gross Margin | -71.21 | -10.28 | -336.62 | - |
| EBIT Margin | -151.64 | -126.54 | -2371.74 | - |
| Profit Margin | -160.24 | -118.39 | -3435.51 | - |
| EBITDA | -45.37 Million | -31.19 Million | -18.04 Million | -484.75 Thousand |
| Earnings Before Tax Margin | -157.77 | -137.82 | -2709.36 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 299.22 Thousand | 299.22 Thousand | -1.05 Million | 2.03 Million | 2.03 Million | 292.35 Thousand |
| Cost of Revenue | - | 3.25 Million | 3.25 Million | 1.56 Million | 7.55 Million | 3.29 Million |
| Gross Profit | 299.22 Thousand | -2.95 Million | -4.3 Million | 462.96 Thousand | -5.51 Million | -3 Million |
| Operating Expenses | 35.63 Million | 18.1 Million | 6.95 Million | 21.56 Million | 6.82 Million | 37.28 Million |
| Selling, General and Administrative Expenses | - | 6.09 Million | 3.82 Million | 6.46 Million | 4.01 Million | - |
| Research and Development Expenses | - | 12.01 Million | 3.99 Million | 15.1 Million | 7.55 Million | - |
| Other Expenses | - | -864.01 Thousand | -864.01 Thousand | - | - | 2.97 Million |
| Cost and Expenses | 38.76 Million | 19.65 Million | 10.2 Million | 23.13 Million | 14.37 Million | 40.58 Million |
| Operating Income | -38.46 Million | -19.35 Million | -11.25 Million | -23.13 Million | -9.53 Million | -40.29 Million |
| Interest Expense | 642.88 Thousand | 605.91 Thousand | - | 36.97 Thousand | - | 86.09 Thousand |
| Income Tax Expense | 96.36 Thousand | 65.14 Thousand | 32.57 Thousand | -3.99 Million | 15.6 Thousand | -5.87 Million |
| Earnings before Tax | -47.85 Million | -23.12 Million | -11.56 Million | -28.75 Million | -12.36 Million | -40.49 Million |
| Net Income | -47.94 Million | -23.19 Million | -11.59 Million | -24.75 Million | -12.37 Million | -34.61 Million |
| Earnings Per Share Basic | - | -0.06 | -0.03 | -0.07 | -0.04 | - |
| Earnings Per Share Diluted | - | -0.06 | -0.03 | -0.07 | -0.04 | - |
| Weighted Average Shares Outstanding | 386.46 Million | 364.87 Million | 429.65 Million | 343.28 Million | 343.29 Million | 323.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 386.46 Million | 364.87 Million | 429.63 Million | 343.28 Million | 343.28 Million | 323.81 Million |
| Gross Margin | 1.00 | -9.87 | 4.09 | 0.23 | -2.71 | -10.28 |
| EBIT Margin | - | -59.49 | 6.98 | -10.61 | -4.30 | - |
| Profit Margin | -160.24 | -77.50 | 11.01 | -12.18 | -6.09 | -118.39 |
| EBITDA | - | -17.8 Million | -7.35 Million | -21.56 Million | -8.74 Million | - |
| Earnings Before Tax Margin | -128.55 | -64.70 | 10.69 | -11.38 | -4.69 | -137.82 |
3707
IMPUY
UBQ
KRSA3
BMN
HPCRF